Exercise-induced Bronchospasm Clinical Trial
Official title:
Evaluation of the Bronchoprotective Effect of Arformoterol in Children With Exercise Induced Bronchospasm
It is our primary hypothesis that pretreatment with arformoterol will provide superior
protection against EIB in children with mild-moderate asthma compared to placebo added to
the current asthma regimen.
Our secondary hypothesis is that nebulized arformoterol has comparable protection against
EIB compared to inhaled formoterol by dry powder inhaler.
This study is a randomized, double-blind, double-dummy, crossover clinical trial which will
consist of 5 study visits and will last up to 3 weeks.
Fifteen children 12-17 years of age with asthma and EIB, regardless of current asthma
therapy will be eligible for this trial.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00375232 -
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
|
N/A | |
| Completed |
NCT00085774 -
Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
|
Phase 3 | |
| Withdrawn |
NCT03610932 -
Vitamin C & Exercise Induced Bronchoconstriction (EIB)
|
N/A | |
| Completed |
NCT00268723 -
Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB
|
Phase 3 | |
| Completed |
NCT00701025 -
Mechanisms of Exercise-induced Bronchospasm
|